Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 14/20 | 0.67 |
| ▸ | P2RY6 | Q15077 | 8/20 | 0.67 |
| ▸ | P2RY14 | Q15391 | 5/20 | 0.61 |
| ▸ | P2RY4 | P51582 | 6/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL3087812 | 0.92 | P2RY2 (0.62) | P2RY2P2RY6P2RY14P2RY4 | |
| SCHEMBL3945904 | 0.90 | SLC28A1 (0.66) | P2RY2P2RY6P2RY14P2RY4 | |
| SCHEMBL657542 | 0.90 | SLC28A1 (0.66) | P2RY2P2RY6P2RY14P2RY4 | |
| SCHEMBL13669613 | 0.90 | SLC28A1 (0.66) | P2RY2P2RY6P2RY14P2RY4 | |
| SCHEMBL13822077 | 0.90 | SLC28A1 (0.66) | P2RY2P2RY6P2RY14P2RY4 | |
| SCHEMBL2056541 | 0.90 | SLC28A1 (0.66) | P2RY2P2RY6P2RY14P2RY4 | |
| SCHEMBL13301520 | 0.90 | SLC28A1 (0.66) | P2RY2P2RY6P2RY14P2RY4 | |
| SCHEMBL3095156 | 0.85 | P2RY2 (0.60) | P2RY2P2RY6P2RY14P2RY4 | |
| SCHEMBL3095149 | 0.85 | P2RY2 (0.60) | P2RY2P2RY6P2RY14P2RY4 | |
| SCHEMBL3087814 | 0.84 | P2RY2 (0.56) | P2RY2P2RY6P2RY14P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8409594-B2 | Solid oil-in-water emulsion | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-04-02 | — | — | US | disclosed |
| US-7794739-B2 | composition for applying to skin containing at least one purine nucleic acid-related substance chosen from adenosine monophosphate and salt thereof, at least one pyrimidine nucleic acid-related substance chosen from uridine monophosphate and salt thereof, and at least one additive; anti-aging, anti-acne | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2010-09-14 | — | — | US | disclosed |
| US-7557093-B2 | Composition for promoting collagen production | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2009-07-07 | — | — | US | disclosed |
| US-20070280979-A1 | Solid Oil-In-Water Emulsion | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-12-06 | — | — | US | disclosed |
| EP-1842522-A1 | SOLID OIL-IN-WATER EMULSION | Otsuka Pharmaceutical Company, Limited (JP) | 2007-10-10 | — | — | EP | disclosed |
| US-20070135374-A1 | Adenosine 5-monophosphate and uridine 5-monophosphate; | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-06-14 | — | — | US | disclosed |
| EP-1671618-A1 | COMPOSITION FOR PROMOTING COLLAGEN PRODUCTION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-06-21 | — | — | EP | disclosed |
| US-20050222076-A1 | Composition for cell proliferation | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-10-06 | — | — | US | disclosed |
| EP-1498101-A1 | COMPOSITION FOR CELL PROLIFERATION | Otsuka Pharmaceutical Company, Limited (JP) | 2005-01-19 | — | — | EP | disclosed |